Table 1.
miRNA ID | Delta Ct | D842V vs. Non-D842V |
p-Value | Predicted Targets among the Deregulated Gene in Our Cohort of Patients * |
---|---|---|---|---|
hsa-miR-1825 | −5.31 | ↑ | 0.027 | NLK(2) |
hsa-miR-431-3p | −4.96 | ↑ | 0.009 | |
hsa-miR-20b-3p | −3.87 | ↑ | 0.015 | |
hsa-miR-149-3p | −3.40 | ↑ | 0.037 | SPRY4(2) |
hsa-miR-9-5p | −2.98 | ↑ | 0.038 | GNPNAT1(2), SIRT1(3), CREB5(2), POU2F1(3), BCL6(3), PXDN(3), RNF169(2), FBN2(3), PTAR1(2), NIN(2) |
hsa-miR-604 | −2.82 | ↑ | 0.044 | |
hsa-miR-661 | −1.64 | ↑ | 0.049 | IL17RA(2) |
hsa-miR-133b | −1.43 | ↑ | 0.032 | PPP2R2D(2), SP1(2), ZHX3(2), CREB5(2), |
hsa-miR-133a-3p | −1.38 | ↑ | 0.044 | |
hsa-miR-1233-3p | −1.07 | ↑ | 0.042 | |
hsa-miR-545-3p | 1.32 | ↓ | 0.048 | TSPAN2(2) |
hsa-miR-210-3p | 1.56 | ↓ | 0.046 | NPTX1(1) |
hsa-miR-221-3p | 1.59 | ↓ | 0.039 | |
hsa-miR-135b-5p | 2.10 | ↓ | 0.027 | |
hsa-miR-33a-5p | 2.12 | ↓ | 0.043 | |
hsa-miR-452-5p | 2.18 | ↓ | 0.044 | |
hsa-miR-219a-5p | 2.43 | ↓ | 0.019 | |
hsa-miR-499a-5p | 2.72 | ↓ | 0.017 | |
hsa-miR-517c-3p | 2.79 | ↓ | 0.024 | |
hsa-miR-873-5p | 3.07 | ↓ | 0.027 | |
hsa-miR-512-3p | 3.60 | ↓ | 0.032 | |
hsa-miR-708-5p | 3.92 | ↓ | 0.002 | |
hsa-miR-122-5p | 4.45 | ↓ | 0.010 | CD320(2) |
hsa-miR-15a-5p | 6.43 | ↓ | 0.025 | RSPO3(2) |
↑: up-regulation; ↓: down-regulation; * in brackets: number of in silico tools predicting the same target which was also deregulated in previous gene expression analysis see ref. [21].